Drug & medication recalls Moderate risk

HYDROmorphone HCl 10 mg in 0 recalled over manufacturing violations

Recall date
May 9, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outso…
Recall number
D-0776-2023
FDA classification
Class II
Brand / firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Sold / distributed
Product was distributed in Missouri.

Why it was recalled

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2

Get recall alerts

Free email alert whenever SSM Health Care St. Louis DBA SSM St. Clare Health Center has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SSM Health Care St. Louis DBA SSM St. Clare Health Center